您的瀏覽器不支援JavaScript功能,若網頁功能無法正常使用時,請開啟瀏覽器JavaScript狀態!
Some images has been designed using resources from
Unsplash
&
Pixabay
&
Pexels
&
Freepik
and some icons from
Flaticon
跳到主要內容
跳到主要內容
:::
回醫療體系歡迎頁
網站導覽
International
Facebook
小
中
大
其他分院
蘇澳分院
員山分院
桃園分院
新竹分院
玉里分院
鳳林分院
台東分院
關渡分院
北榮民總醫院技術移轉組
Worlds Best Hospitals
搜尋
打開主選單
站內檢索
站內檢索
最新消息
最新公告
活動訊息
重大新聞
產官學研大平台
關於我們
相關法規/常用表單
現有計畫
連絡我們
單位簡介
單位簡介
法律依據
組織架構
工作職掌
服務項目
合作研發
檢驗測試
諮詢顧問
授權實施
專利申請
其他服務
研發成果
技術移轉徵選廠商公告
可授權專利
中華民國專利
美國專利
產品資訊
專利讓與公告
歷次專利讓與公告彙總
常用表單
管理要點
合作研發表格
臨床試驗表格
檢驗測試表格
授權實施表格
專利申請表格
產官學合作計畫暨臨床試驗計畫管理系統
常見問題
一般問題
申請專利
技術移轉
產官學合作
聯絡我們
地理位置
聯絡資料
站內檢索
站內檢索
最新消息
最新公告
活動訊息
重大新聞
產官學研大平台
關於我們
相關法規/常用表單
現有計畫
連絡我們
單位簡介
單位簡介
法律依據
組織架構
工作職掌
服務項目
合作研發
檢驗測試
諮詢顧問
授權實施
專利申請
其他服務
研發成果
技術移轉徵選廠商公告
可授權專利
中華民國專利
美國專利
產品資訊
專利讓與公告
歷次專利讓與公告彙總
常用表單
管理要點
合作研發表格
臨床試驗表格
檢驗測試表格
授權實施表格
專利申請表格
產官學合作計畫暨臨床試驗計畫管理系統
常見問題
一般問題
申請專利
技術移轉
產官學合作
聯絡我們
地理位置
聯絡資料
回醫療體系歡迎頁
網站導覽
English
International
BranchesHospital
SuaoHospital
YuanshanHospital
TaoyuanHospital
HsinchuHospital
YuLiHospital
FenglinHospital
TaitungHospital
GanDauHospital
Facebook
首頁
簡介
:::
郭錦松 (Chin-Sung Kuo)
複診掛號
初診掛號
[簡介]
學歷
National Yang Ming Chiao Tung University Institute of Clinical Medicine,
National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan.
經歷
現職:
- 迄今 Attending Physician, Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
- 迄今 Lecturer, Department of Medicine, National Yang-Ming University, Taipei, Taiwan.
- 迄今 Clinical Associate professor, School of Medicine, National Defense Medical Center, Taipei, Taiwan
- 迄今 Executive Director, Taiwan Diabetes Association, Taipei, Taiwan
經歷:
- Visiting Assistant Researcher, Division of Diabetes and Metabolism, Endocrinology, University of California, Irvine, CA, USA.
- President, Taiwan Diabetes Association, Taipei, Taiwan.
- Deputy Secretory General, The Endocrine Society of the R.O.C.
- Deputy Director, Department of Research, Buddhist Dalin Tzu Chi General Hospital, Taiwan.
- Chief, Division of Endocrinology and Metabolism, Department of Medicine, Buddhist Dalin Tzu Chi General Hospital, Taiwan.
- Assistant Professor, Department of Medicine, Tzu Chi University, Taiwan.
醫療專長
Diabetes and its complication, hyperuricemia, thyroid disease, adrenal gland, dyslipidemia, obesity, pituitary gldisease
證照
Certification of National Physician’s Board, Taiwan.
Certification of Specialist in Internal Medicine, Taiwan.
Certification of Diabetes Educators, Taiwan
Certification of Specialist in Endocrinology and Metabolism, Taiwan.
[著作]
第一作者
Kuo CS, Kuo NR, Yeh YK, Lee YJ, Chuang LM, Chen HF, Chen CC, Lee CC, Hsu CC, Li HY, Ou HY, Hwu CM. Residual risk of cardiovascular complications in statin-using patients with type 2 diabetes: the Taiwan Diabetes Registry Study. Lipids Health Dis. 2024 Jan 23. [IF 3.9]
共同第一作者
Kuo CS, Chen HS. β-cell function and long-term glycemic control in patients newly diagnosed with type 2 diabetes with moderate hyperglycemia after a 6-month course of basal insulin therapy. Diabetes Res Clin Pract. 2024 Aug 8. [IF 6.1]
通訊作者
Po-Sheng Lee, Jui-Yu Chen, Li-Hsin Pan, Chii-Min Hwu, Jen-Fan Hang, Chin-Sung Kuo. Unveiling a rare BRAF mutation in minimally invasive follicular thyroid carcinoma: A case report. Medicine. 2024 August 23 [IF 1.3]
Li-Hsin Pan, Jen-Fan Hang, Jui-Yu Chen, Po-Sheng Lee, Yun-Kai Yeh, Tai-Jung Huang, Chii-Min Hwu, Chin-Sung Kuo. Difficulties of Pre-operative Diagnosis of Cribriform Morular Thyroid Carcinoma: A Case Report. Case Rep Endocrinol. 2024 May 28. [IF 1.1]
共同作者
Lai HF, Hang JF, Kuo PC, Kuo CS, Yao SF, Chen JY, Lee CH. BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma. Ann Surg Oncol. 2024 Feb 1. [IF 3.4]
Lai HF, Hang JF, Kuo PC, Kuo CS*, Yao SF, Chen JY, Lee CH. BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma. Ann Surg Oncol. 2024 Feb 1. [IF 3.7]
Chen KL, Chou RH, Chang CC, Kuo CS*, Wei JH, Huang PH, Lin SJ. The high-density lipoprotein cholesterol (HDL-C)-concentration-dependent association between anti-inflammatory capacity and sepsis: A single-center cross-sectional study. PLoS One. 2024 Apr 11. [IF 3.7]
Shen FC, ……, Kuo CS*, …..., Sheu WH, Huang CN, Wang CY, Ou HY. Optimizing Lipid Control in Taiwanese Diabetic Patients: A Collaborative Consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators. Journal of Diabetes Investigation. 2024 Aug. [IF 3.2]
Jee-Fu Huang, ……, Chin-Sung Kuo, ……, Ming-Lung Yu. Taiwan Position Statement of Patients with Diabetes and Steatotic Liver Disease. Hepatology Communications 2024 accepted. [IF 5.6]
Chen CE, Guo JY, Chou RH, Wu CH, Kuo CS, Wei JH, Huang PH. Circulating corin concentration is associated with risk of mortality and acute kidney injury in critically ill patients. Sci Rep. 2024 Aug 27. [IF 3.8]
Huang JF, ……, Kuo CS, ……, Yu ML. Clinical care guidance in patients with diabetes and metabolic dysfunction-associated steatotic liver disease: A joint consensus. Hepatol Commun. 2024 Oct 30. [IF 5.6]